| Not Yet Recruiting | A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R Healthy Adult Participants | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Gastric (Stomach) Cancer, GastroEsophageal Cancer, Pancreatic Ductal Adenocarcinoma (mPDAC) | Phase 1 | 2026-02-01 |
| Completed | Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State Healthy | Phase 1 | 2026-01-06 |
| Completed | Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State Healthy | Phase 1 | 2025-12-14 |
| Not Yet Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Diabete Mellitus | Phase 2 | 2025-11-01 |
| Recruiting | A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects Healthy Adult | Phase 1 | 2025-11-01 |
| Not Yet Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes Diabete Mellitus | Phase 4 | 2025-11-01 |
| Enrolling By Invitation | Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects Infective Disorder | Phase 1 | 2025-10-20 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Ad Healthy Adults | Phase 1 | 2025-07-16 |
| Completed | Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and Healthy | Phase 1 | 2025-07-07 |
| Completed | A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult | Phase 1 | 2025-07-04 |
| Not Yet Recruiting | Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and Healthy | Phase 1 | 2025-06-01 |
| Not Yet Recruiting | To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects Healthy | Phase 1 | 2025-05-21 |
| Not Yet Recruiting | Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 an Healthy | Phase 1 | 2024-09-30 |
| Completed | The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis Lumbar Spinal Stenosis | — | 2024-08-16 |
| Not Yet Recruiting | A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants Healthy | Phase 1 | 2024-05-07 |
| Recruiting | Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-450 Locally Advanced or Metastatic Solid Tumors | Phase 1 / Phase 2 | 2024-04-18 |
| Active Not Recruiting | Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients Type 2 Diabetes | Phase 3 | 2024-04-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis Gastritis Acute, Gastritis Chronic | Phase 3 | 2024-01-31 |
| Completed | Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults Healthy | Phase 1 | 2023-08-22 |
| Completed | Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults Healthy | Phase 1 | 2023-08-18 |
| Completed | Clinical Trial of DA-5212 in Patients with Functional Dyspepsia Functional Dyspepsia | Phase 3 | 2023-06-06 |
| Completed | A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010 Renal Impairment, Healthy | Phase 1 | 2023-05-02 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in P Diabetes Mellitus | Phase 4 | 2023-04-25 |
| Unknown | Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State Healthy | Phase 1 | 2023-03-30 |
| Unknown | Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State Healthy | Phase 1 | 2023-03-25 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients Hepatitis B | Phase 4 | 2023-03-20 |
| Unknown | Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State Healthy | Phase 1 | 2023-03-18 |
| Unknown | Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State Healthy | Phase 1 | 2023-03-17 |
| Completed | Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women Postmenopausal Osteoporosis | Phase 4 | 2023-01-03 |
| Unknown | A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evalua Healthy | Phase 1 | 2022-08-29 |
| Unknown | Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5 Healthy | Phase 1 | 2022-07-08 |
| Completed | A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder Overactive Bladder | Phase 3 | 2022-05-12 |
| Unknown | Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab" Healthy | Phase 1 | 2022-05-01 |
| Completed | Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects Healthy | Phase 1 | 2021-12-21 |
| Completed | Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and D Healthy | Phase 1 | 2021-12-18 |
| Completed | Phase 1 Clinical Trial of DA-5207 in Healthy Adults Healthy | Phase 1 | 2021-11-25 |
| Completed | Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State Healthy | Phase 1 | 2021-11-07 |
| Completed | Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State Healthy | Phase 1 | 2021-10-31 |
| Completed | Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State Healthy | Phase 1 | 2021-10-28 |
| Completed | Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State Healthy | Phase 1 | 2021-10-26 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects Hepatitis B | Phase 1 | 2021-07-12 |
| Completed | Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811) Healthy | Phase 1 | 2021-07-08 |
| Completed | Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Sev Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2021-04-28 |
| Recruiting | Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome | — | 2021-02-08 |
| Completed | The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Heal Healthy | Phase 1 | 2021-01-13 |
| Unknown | A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET Diabetes Mellitus, Type 2, Renal Disease, Diabetes Mellitus | Phase 4 | 2020-12-01 |
| Completed | Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab" Healthy | Phase 1 | 2020-11-23 |
| Completed | Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects Healthy | Phase 1 | 2020-08-04 |
| Unknown | Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults Healthy | Phase 1 | 2020-07-28 |
| Completed | The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients Hemodialysis Patients | Phase 1 | 2020-07-10 |
| Completed | Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Pat Type 2 Diabetes | Phase 3 | 2020-05-26 |
| Unknown | Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab" Healthy | Phase 1 | 2020-03-30 |
| Unknown | Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab. Diabetes Mellitus, Type 2 | — | 2020-03-25 |
| Completed | Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Pat Type2 Diabetes | Phase 3 | 2020-01-02 |
| Unknown | BE Study of Gaster®D Tab 20mg (Manufacturer Changed) Gastroduodenal Ulcer | N/A | 2019-10-11 |
| Completed | Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD Calcific Aortic Valve Disease | Phase 2 | 2019-08-26 |
| Completed | Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults Healthy | Phase 1 | 2019-06-18 |
| Completed | Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab" Healthy | N/A | 2019-04-23 |
| Completed | Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases Type2 Diabetes, Non-Alcoholic Fatty Liver Disease | Phase 4 | 2019-04-12 |
| Completed | A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State Type2 Diabetes | Phase 1 | 2019-02-07 |
| Completed | A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State Type2 Diabetes | Phase 1 | 2019-02-07 |
| Completed | Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Type2 Diabetes | Phase 1 | 2018-11-22 |
| Completed | A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With Diabetes Mellitus, Type 2 | Phase 1 | 2018-08-29 |
| Completed | A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder Overactive Bladder | Phase 2 | 2018-07-10 |
| Completed | Safety and Efficacy of DA-9805 for Parkinson's Disease Parkinson's Disease | Phase 2 | 2018-02-06 |
| Completed | Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycos Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | 2017-11-10 |
| Completed | Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in He Healthy | Phase 1 | 2017-05-29 |
| Completed | A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects Diabetes Mellitus, Type 2 | Phase 1 | 2017-03-29 |
| Completed | Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients Hepatitis B， Chronic | Phase 3 | 2017-03-28 |
| Completed | A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Pa Breast Cancer | Phase 3 | 2017-01-12 |
| Completed | Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg Type2 Diabetes | Phase 1 | 2016-11-14 |
| Completed | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatr Solid Tumor, Lymphoma | Phase 1 | 2016-10-04 |
| Completed | Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction Liver Dysfunction | Phase 1 | 2016-09-22 |
| Completed | Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabe Type2 Diabetes | Phase 4 | 2016-09-01 |
| Completed | Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg Type 2 Diabetes | Phase 1 | 2016-07-27 |
| Completed | Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia Androgenic Alopecia | Phase 1 | 2016-07-01 |
| Unknown | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects Overactive Bladder | Phase 1 | 2016-06-01 |
| Completed | Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease Alzheimer Disease | Phase 4 | 2016-04-01 |
| Unknown | To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex) Anemia of Chronic Kidney Disease | Phase 3 | 2016-03-01 |
| Completed | Efficacy and Safety of DA-3002 in Short Children Borns SGA. Infant, Small for Gestational Age | Phase 3 | 2016-02-26 |
| Completed | Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Hea Healthy | Phase 1 | 2016-02-01 |
| Completed | Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2015-11-02 |
| Unknown | To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Vo Healthy | Phase 1 | 2015-11-01 |
| Completed | Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Vol Healthy | Phase 1 | 2015-10-06 |
| Completed | Study of Motilitone to Treat Functional Dyspepsia Dyspepsia | Phase 2 | 2015-06-01 |
| Completed | A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR Type 2 Diabetes Mellitus | Phase 1 | 2015-04-01 |
| Completed | The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled Wi Hypertension | Phase 4 | 2015-03-16 |
| Completed | Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Kn Osteoarthritis, Knee | Phase 2 | 2014-12-23 |
| Terminated | A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients Chronic Myeloid Leukemia | Phase 4 | 2014-10-13 |
| Unknown | Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229 Healthy | Phase 1 | 2014-09-01 |
| Completed | Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia Hyperlipidemia | Phase 4 | 2014-09-01 |
| Completed | A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen) Symptomatic Anemia | Phase 1 | 2014-08-18 |
| Completed | PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients Renal Impairment | Phase 1 | 2014-07-01 |
| Completed | A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administ Type 2 Diabetes Mellitus | Phase 1 | 2014-07-01 |
| Completed | Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Healthy | Phase 1 | 2014-05-01 |
| Completed | Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH Pulmonary Arterial Hypertension | Phase 2 / Phase 3 | 2014-04-01 |
| Unknown | A Study to Evaluate the Efficacy and Safety of DA-5204 Acute Gastritis, Chronic Gastritis | Phase 3 | 2014-04-01 |
| Completed | Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application Androgenetic Alopecia | Phase 1 / Phase 2 | 2014-01-01 |
| Completed | Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B HBeAg-Positive Chronic Hepatitis B | Phase 4 | 2013-09-12 |
| Completed | A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin Type 2 Diabetes Mellitus | Phase 3 | 2013-07-01 |
| Completed | Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2013-05-01 |
| Completed | A Clinical Study to Assess the Efficacy and Safety of DA-3002 Turner's Syndrome | Phase 3 | 2013-02-01 |
| Completed | A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Acute Gastritis, Chronic Gastritis | Phase 4 | 2012-10-01 |
| Completed | A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601 NSAID-associated Gastroduodenal Injury | Phase 4 | 2012-09-01 |
| Completed | Phase I Clinical Trial of DA-6886 in Healthy Male Subjects Irritable Bowel Syndrome | Phase 1 | 2012-08-01 |
| Completed | A Study to Demonstrate the Efficacy and Safety of Motilitone® Functional Dyspepsia | Phase 4 | 2012-08-01 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film- Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumor | Phase 1 | 2012-05-01 |
| Completed | Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome Dry Eye Syndrome | Phase 2 | 2012-04-01 |
| Completed | Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia Chemotherapy Induced Neutropenia | Phase 3 | 2012-02-01 |
| Completed | Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature Idiopathic Short Stature | Phase 3 | 2012-02-01 |
| Completed | Study of DA-9801 to Treat Diabetic Neuropathic Pain Diabetic Neuropathies | Phase 2 | 2011-11-01 |
| Completed | Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration Atherosclerosis | Phase 1 | 2011-09-01 |
| Completed | Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) Pulmonary Arterial Hypertension | Phase 2 | 2011-08-01 |
| Completed | Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia Chemotherapy Induced Neutropenia | Phase 2 | 2010-07-01 |
| Completed | The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers Healthy | Phase 1 | 2009-09-01 |
| Completed | Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers Dry Eye Syndrome | Phase 1 | 2008-09-01 |
| Completed | A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F® Infertility, Anovulation | Phase 3 | 2007-01-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Opt Acute Gastritis, Chronic Gastritis | Phase 2 | 1997-03-14 |
| Completed | Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Healthy Volunteers | Phase 1 | — |